Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth ▾	Diluted EPS
NUVB	Nuvation Bio Inc. Manufacturing · Year ended 2025-12-31 · USD	$62.90M	-$204.63M	-325.3%	-66.9%	699.0%	-$0.60
SNDX	Syndax Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$172.35M	-$285.42M	-165.6%	-441.6%	627.8%	-$3.29
CRMD	CorMedix Inc. Manufacturing · Year ended 2025-12-31 · USD	$311.71M	$163.06M	52.3%	40.2%	617.0%	$2.04
XLO	Xilio Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$43.77M	-$35.04M	-80.1%	-99.3%	589.9%	-$4.19
BIOE	Bio Essence Corp Manufacturing · Year ended 2025-12-31 · USD	$1.90M	$896.2K	47.2%	n/a	485.8%	n/a
SCYX	Scynexis Inc Manufacturing · Year ended 2025-12-31 · USD	$20.60M	-$8.61M	-41.8%	-17.4%	449.9%	-$0.17
CAMP	Camp4 Therapeutics Corp Manufacturing · Year ended 2025-12-31 · USD	$3.50M	-$80.40M	n/m	-168.5%	436.5%	-$2.65
MDGL	Madrigal Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$958.40M	-$288.28M	-30.1%	-47.8%	432.1%	-$12.85
STOK	Stoke Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$184.42M	-$6.88M	-3.7%	-2.0%	404.5%	-$0.12
CYTK	Cytokinetics Inc Manufacturing · Year ended 2025-12-31 · USD	$88.04M	-$784.96M	-891.6%	n/a	376.6%	-$6.54
VRCA	Verrica Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	$35.58M	-$17.89M	-50.3%	-72.3%	370.2%	-$1.68
ZVRA	Zevra Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$106.47M	$83.23M	78.2%	53.8%	350.9%	$1.35
PHAT	Phathom Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$175.11M	-$221.25M	-126.3%	n/a	216.9%	-$3.03
SCNX	Scienture Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$431.6K	-$41.51M	n/m	-59.2%	215.9%	-$2.70
VSTM	Verastem, Inc. Manufacturing · Year ended 2025-12-31 · USD	$30.91M	-$209.47M	-677.6%	-366.2%	209.1%	-$3.02
CUE	Cue Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$27.47M	-$26.60M	-96.9%	-100.6%	195.7%	-$0.28
KRRO	Korro Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$6.39M	-$117.26M	n/m	-228.0%	181.5%	-$12.48
VREOF	Vireo Growth Inc. Manufacturing · Year ended 2025-12-31 · USD	$268.77M	-$68.11M	-25.3%	-22.2%	170.4%	-$0.09
VTGN	Vistagen Therapeutics, Inc. Manufacturing · Year ended 2026-03-31 · USD	$1.27M	-$69.69M	n/m	-196.2%	161.1%	-$1.83
ABCL	AbCellera Biologics Inc. Manufacturing · Year ended 2025-12-31 · USD	$75.13M	-$146.41M	-194.9%	-15.1%	160.6%	-$0.49
ANAB	Anaptysbio, Inc Manufacturing · Year ended 2025-12-31 · USD	$234.60M	-$13.23M	-5.6%	-35.6%	157.0%	-$0.46
ASMB	Assembly Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$72.30M	-$6.12M	-8.5%	-3.0%	153.5%	-$0.55
PGEN	Precigen, Inc. Manufacturing · Year ended 2025-12-31 · USD	$9.68M	-$250.64M	n/m	n/m	146.7%	-$1.37
SER	Serina Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$130.0K	-$19.18M	n/m	n/a	132.1%	-$1.91
ABUS	Arbutus Biopharma Corp Manufacturing · Year ended 2025-12-31 · USD	$14.08M	-$33.50M	-237.9%	-43.7%	128.2%	-$0.17
BBIO	BridgeBio Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$502.08M	-$732.94M	-146.0%	n/a	126.3%	-$3.78
COYA	Coya Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.95M	-$21.23M	-267.1%	-49.3%	123.6%	-$1.27
ARQT	Arcutis Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$372.07M	-$16.14M	-4.3%	-8.5%	123.4%	-$0.13
PTCT	PTC Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.73B	$682.64M	39.4%	n/a	114.5%	$7.78
TVTX	Travere Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$490.73M	-$25.55M	-5.2%	-22.2%	110.5%	-$0.29
BCYC	Bicycle Therapeutics PLC Manufacturing · Year ended 2025-12-31 · USD	$72.59M	-$218.96M	-301.7%	-35.9%	105.8%	-$3.16
ALT	Altimmune, Inc. Manufacturing · Year ended 2025-12-31 · USD	$41.0K	-$88.09M	n/m	-39.2%	105.0%	-$1.00
ETON	Eton Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$79.95M	-$4.60M	-5.8%	-17.6%	104.9%	n/a
ZBIO	Zenas BioPharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.00M	-$377.74M	n/m	-156.0%	100.0%	-$8.44
TGTX	TG Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$616.29M	$447.18M	72.6%	69.0%	87.3%	$2.77
EVMN	Evommune, Inc. Manufacturing · Year ended 2025-12-31 · USD	$13.00M	-$68.87M	-529.8%	-33.5%	85.7%	-$11.22
ELTP	Elite Pharmaceuticals Inc Manufacturing · Year ended 2026-03-31 · USD	$148.87M	$44.87M	30.1%	45.4%	77.1%	$0.03
PRLD	Prelude Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	$12.14M	-$99.50M	-819.6%	-145.0%	73.4%	-$1.29
TXMD	TherapeuticsMD, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.02M	-$569.0K	-18.8%	-2.1%	71.6%	-$0.05
SLGL	Sol-Gel Technologies Ltd. Manufacturing · Year ended 2025-12-31 · USD	$19.39M	-$6.13M	-31.6%	-26.9%	68.0%	-$2.19
TBPH	Theravance Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$107.46M	$105.89M	98.5%	35.7%	66.9%	$2.06
INSM	Insmed Inc Manufacturing · Year ended 2025-12-31 · USD	$606.42M	-$1.28B	-210.5%	-172.8%	66.7%	-$6.42
CPMD	Cannapharmarx, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.36M	-$11.13M	-817.2%	n/a	66.1%	-$0.02
AXSM	Axsome Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$638.50M	-$183.17M	-28.7%	-207.5%	65.5%	-$3.68
SXTP	60 Degrees Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.01M	-$7.37M	-732.5%	-212.7%	65.5%	-$11.73
ALNY	Alnylam Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.71B	$313.75M	8.4%	39.8%	65.2%	$2.33
LGND	Ligand Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$268.09M	$124.45M	46.4%	12.2%	60.4%	$6.13
LXRX	Lexicon Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$49.80M	-$50.34M	-101.1%	-46.8%	60.2%	-$0.14
KNSA	Kiniksa Pharmaceuticals International, plc Manufacturing · Year ended 2025-12-31 · USD	$677.56M	$59.01M	8.7%	10.4%	60.1%	$0.75
RANI	Rani Therapeutics Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.63M	-$40.95M	n/m	-124.1%	58.9%	-$0.45
MIRM	Mirum Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$521.31M	-$23.36M	-4.5%	-7.4%	54.7%	-$0.47
NRIX	Nurix Therapeutics, Inc. Manufacturing · Year ended 2025-11-30 · USD	$83.98M	-$264.46M	-314.9%	-49.1%	54.0%	-$3.05
LEXX	Lexaria Bioscience Corp. Manufacturing · Year ended 2025-08-31 · USD	$705.9K	-$11.90M	n/m	-398.1%	52.0%	-$0.66
BGM	BGM Group Ltd. Manufacturing · Year ended 2025-09-30 · USD	$37.92M	-$19.94M	-52.6%	-5.1%	51.1%	-$0.18
TNGX	Tango Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$62.38M	-$101.59M	-162.9%	-29.3%	48.3%	-$0.87
AGIO	Agios Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$54.03M	-$412.78M	-764.0%	-34.6%	48.0%	-$7.12
AKBA	Akebia Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$236.20M	-$5.34M	-2.3%	-16.4%	47.5%	-$0.02
RYTM	Rhythm Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$189.76M	-$196.54M	-103.6%	-141.3%	45.8%	-$3.11
LLY	Eli Lilly & Co Manufacturing · Year ended 2025-12-31 · USD	$65.18B	$20.64B	31.7%	77.8%	44.7%	$22.95
BDPT	Bioadaptives, Inc. Manufacturing · Year ended 2025-12-31 · USD	$18.3K	-$1.56M	n/m	n/a	44.3%	-$0.15
RFL	Rafael Holdings, Inc. Manufacturing · Year ended 2025-07-31 · USD	$917.0K	-$30.52M	n/m	-31.0%	44.0%	-$1.04
ANIP	ANI Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$883.37M	$78.34M	8.9%	14.5%	43.8%	$3.32
XERS	Xeris Biopharma Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$291.85M	$554.0K	0.2%	4.0%	43.7%	$0.00
ONC	BeOne Medicines Ltd. Manufacturing · Year ended 2025-12-31 · USD	$5.34B	$286.93M	5.4%	6.6%	40.2%	$0.19
SPRO	Spero Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$66.80M	$8.57M	12.8%	14.5%	39.2%	$0.15
ZYME	Zymeworks Inc. Manufacturing · Year ended 2025-12-31 · USD	$105.97M	-$81.13M	-76.6%	-30.2%	38.9%	-$1.08
BHST	Bioharvest Sciences Inc. Manufacturing · Year ended 2025-12-31 · USD	$34.51M	-$11.13M	-32.3%	-43.8%	37.0%	n/a
FHTX	Foghorn Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$30.91M	-$74.28M	-240.3%	n/a	36.8%	-$1.18
HROW	Harrow, Inc. Manufacturing · Year ended 2025-12-31 · USD	$272.30M	-$5.14M	-1.9%	-9.8%	36.4%	-$0.14
RLYB	Rallybio Corp Manufacturing · Year ended 2025-12-31 · USD	$858.0K	-$8.98M	n/m	-15.5%	34.9%	-$1.59
IONS	Ionis Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$943.71M	-$381.39M	-40.4%	-78.0%	33.8%	-$2.38
TNXP	Tonix Pharmaceuticals Holding Corp. Manufacturing · Year ended 2025-12-31 · USD	$13.11M	-$124.02M	-946.2%	-50.6%	29.8%	-$14.57
IRD	Opus Genetics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$14.20M	-$49.59M	-349.3%	-323.1%	29.1%	-$0.80
KURA	Kura Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$67.48M	-$278.67M	-412.9%	-160.0%	25.2%	-$3.18
HIND	Vyome Holdings, Inc Manufacturing · Year ended 2025-12-31 · USD	$319.7K	-$10.26M	n/m	-272.8%	24.4%	-$4.86
COLL	Collegium Pharmaceutical, Inc Manufacturing · Year ended 2025-12-31 · USD	$780.57M	$62.87M	8.1%	20.8%	23.6%	$1.73
SDGR	Schrodinger, Inc. Manufacturing · Year ended 2025-12-31 · USD	$255.87M	-$103.27M	-40.4%	-28.4%	23.3%	-$1.41
MNKD	MannKind Corp Manufacturing · Year ended 2025-12-31 · USD	$348.97M	$5.86M	1.7%	n/a	22.2%	$0.02
ARDX	Ardelyx, Inc. Manufacturing · Year ended 2025-12-31 · USD	$407.32M	-$61.60M	-15.1%	-36.9%	22.1%	-$0.26
HRMY	Harmony Biosciences Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$868.45M	$158.69M	18.3%	18.2%	21.5%	$2.71
URGN	UroGen Pharma Ltd. Manufacturing · Year ended 2025-12-31 · USD	$109.79M	-$153.49M	-139.8%	n/a	21.4%	n/a
UPB	Upstream Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.85M	-$143.44M	n/m	-42.2%	20.4%	-$2.66
RARE	Ultragenyx Pharmaceutical Inc. Manufacturing · Year ended 2025-12-31 · USD	$673.00M	-$575.00M	-85.4%	n/a	20.2%	-$5.83
XBIO	Xenetic Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.98M	-$2.68M	-90.1%	-36.2%	19.0%	-$1.58
CPIX	Cumberland Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$44.52M	-$2.84M	-6.4%	-11.4%	17.6%	-$0.19
ZOMDF	Zomedica Corp. Manufacturing · Year ended 2025-12-31 · USD	$32.03M	-$81.86M	-255.6%	-70.9%	17.4%	-$0.08
PAHC	Phibro Animal Health Corp Manufacturing · Year ended 2026-06-30 · USD	$1.52B	$99.72M	6.6%	25.9%	17.1%	$2.43
ORGO	Organogenesis Holdings Inc. Manufacturing · Year ended 2025-12-31 · USD	$564.17M	$37.03M	6.6%	12.3%	17.0%	$0.15
SRPT	Sarepta Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.20B	-$713.41M	-32.5%	-62.5%	15.6%	-$7.13
ZLAB	Zai Lab Ltd Manufacturing · Year ended 2025-12-31 · USD	$457.18M	-$175.54M	-38.4%	-24.5%	15.0%	-$0.16
ADCT	ADC Therapeutics SA Manufacturing · Year ended 2025-12-31 · USD	$81.36M	-$142.62M	-175.3%	n/a	14.9%	-$1.12
INVA	Innoviva, Inc. Manufacturing · Year ended 2025-12-31 · USD	$411.33M	$271.17M	65.9%	23.1%	14.7%	$3.30
YARW	Yarrow Bioscience, Inc. Manufacturing · Year ended 2025-12-31 · USD	$570.0K	-$26.48M	n/m	-95.4%	13.8%	-$0.62
XNCR	Xencor Inc Manufacturing · Year ended 2025-12-31 · USD	$125.58M	-$91.92M	-73.2%	-14.5%	13.7%	-$1.24
BMRN	BioMarin Pharmaceutical Inc Manufacturing · Year ended 2025-12-31 · USD	$3.22B	$348.90M	10.8%	5.7%	12.9%	$1.80
CORT	Corcept Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	$761.41M	$99.65M	13.1%	15.4%	12.8%	$0.82
CYRX	Cryoport, Inc. Manufacturing · Year ended 2025-12-31 · USD	$176.18M	$78.30M	44.4%	15.6%	12.4%	$1.40
ACAD	Acadia Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$1.07B	$391.00M	36.5%	31.9%	11.9%	$2.30
BFRI	Biofrontera Inc. Manufacturing · Year ended 2025-12-31 · USD	$41.70M	-$10.54M	-25.3%	-100.5%	11.7%	-$1.04
EOLS	Evolus, Inc. Manufacturing · Year ended 2025-12-31 · USD	$297.18M	-$51.64M	-17.4%	n/a	11.6%	-$0.80

Rows per page: 25 50100